We were neither able to find differences in levels of serum ACSL4 or AIFM2 between patients and controls, nor were we able to identify significant associations between clinical disease and these two molecules previously linked to ferroptosis in preclinical models of COPD. This evidence concerns the gene ACSL4 and chronic obstructive pulmonary disease.